A UCLA-led study on a two-drug therapy combining injectable naltrexone and extended-release bupropion showed significant reductions in methamphetamine use among participants up to 12 weeks into treatment.
Research from
A UCLA-led study on a two-drug therapy combining injectable naltrexone and extended-release bupropion showed significant reductions in methamphetamine use among participants up to 12 weeks into treatment.
Research from

1251 Wilcrest Drive
Houston, Texas
77042 USA
Call-832.795.1420
e-mail – news@theinsightpost.com
Theinsightpost ©2026 | All Rights Reserved. Theinsightpost is an Elnegy LLC company, registered in Texas, USA
Discussion about this post